Edmond de Rothschild Holding’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Edmond de Rothschild Holding’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-240,300	Closed	-$2.99M	–	603
2019 Q2	$2.99M	Sell	240,300 -20,000	-8%	-$266K	0.11%	150
2019 Q1	$3.78M	Hold	260,300	–	–	0.13%	133
2018 Q4	$2.87M	Buy	260,300 +25,000	+11%	+$348K	0.1%	142
2018 Q3	$6.19M	Sell	235,300 -65,073	-22%	-$1.76M	0.18%	112
2018 Q2	$6.14M	Sell	300,373 -52,927	-15%	-$1.14M	0.18%	118
2018 Q1	$6.41M	Sell	353,300 -86,700	-20%	-$1.45M	0.19%	122
2017 Q4	$6.14M	Hold	440,000	–	–	0.18%	118
2017 Q3	$8.14M	Hold	440,000	–	–	0.23%	94
2017 Q2	$7.44M	Buy	440,000 +20,000	+5%	+$304K	0.21%	108
2017 Q1	$5.61M	Buy	+420,000	New	+$6.58M	0.15%	116

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Edmond de Rothschild Holding's MNTA Position: Q3 2019 in Review

Edmond de Rothschild Holding sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2019, closing a stake of 240,300 shares — an estimated $2.99M sold.

Edmond de Rothschild Holding first reported a position in MNTA in Q1 2017 and held it in 10 quarters. The position peaked at $8.14M in Q3 2017. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

Edmond de Rothschild Holding reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Edmond de Rothschild Holding sold 240,300 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $2.99M.
Edmond de Rothschild Holding first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 10 quarters.
Edmond de Rothschild Holding's Momenta Pharmaceuticals, Inc. position peaked at $8.14M in Q3 2017.
154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2019, filed 14 Nov 2019.